2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Enrollment Completed in ARISE II Pivotal Trial for Neuravi's EmboTrap II Revascularization Device

February 22, 2017 -- Neuravi announced completion of enrollment ahead of schedule in the company’s ARISE II international clinical trial assessing the safety and ef…

Teleflex Completes Acquisition of Vascular Solutions

February 22, 2017 -- Teleflex Incorporated announced last week the completion of its acquisition of Vascular Solutions, Inc., a developer of clinical solut…

ASTER Evaluates Penumbra’s Aspiration System in Acute Ischemic Stroke

February 22, 2017 -- Penumbra, Inc. announced the presentation of results from the ASTER trial at the International Stroke Conference in Houston, Texas. ASTER i…

Philips Launches Next-Generation Azurion Image-Guided Therapy Platform

February 22, 2017 -- Royal Philips announced the global launch of Azurion, the company's next-generation image-guided therapy platform for interventional labs. Accordin…

Medtronic’s OsteoCool System Granted Expanded Indication by FDA for the Palliative Treatment of Metastatic Bone Tumors

February 15, 2017 -- Medtronic announced that the US Food and Drug Administration has approved an expanded indication for its OsteoCool RF Ablation System for the palliat…

One-Year Data Presented for B. Braun's SeQuent Please Over-the-Wire Drug-Coated Balloon

February 14, 2017 -- One-year clinical trial data regarding use of B. Braun Melsungen AG’s SeQuent Please Over-the-Wire (OTW) drug-coated balloon (DCB) in femoropop…

Click here for more News coverage

Current Supplement

Sponsored by BOLTON MEDICAL

Ahead of the Curve

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Video

Sponsored by Intact Vascular

Addressing Post-PTA Dissections with a Unique and Novel Approach

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $45.01  0.00%
AstraZeneca PLC $28.92  -0.31%
Avinger $2.30  -4.17%
Boston Scientific Corporation $25.16  -0.47%
Cardinal Health $81.08  -0.32%
Cardiovascular Systems Inc. $27.54  -2.24%
CR Bard Inc. $243.38  0.06%
Edwards Lifesciences Corp. $92.21  -0.50%
Endologix Inc. $6.53  0.62%
Vascular Market Price  Change
Johnson and Johnson $119.52  -0.11%
Lombard Medical, Inc. $0.63  3.01%
Medtronic, Inc. $79.62  -1.15%
Merit Medical Systems, Inc. $29.92  4.43%
Penumbra, Inc. $78.85  -0.76%
Stryker $127.29  0.10%
The Medicines Company $52.22  -2.08%
The Spectranetics Corporation $26.80  -0.92%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.